Brief: Accrelist Intends To Conduct A Strategic Review

Accrelist

14/11/2019 15:17

Nov 14 (Reuters) - Accrelist Ltd  ACCR.SI :
    * INTENDS TO CONDUCT A STRATEGIC REVIEW
    * STRATEGIC REVIEW IS INTENDED TO EVALUATE POSITIONING OF
GROUP AS
FIRST PURE MEDICAL AESTHETICS COMPANY
    * SHAREHOLDERS SHOULD NOTE THAT THERE IS NO ASSURANCE ANY
TRANSACTION WILL MATERIALISE ARISING FROM STRATEGIC REVIEW
    * INTENDS TO CONTINUE TO FOCUS ITS RESOURCES TO DEVELOP
GROUP'S
MEDICAL AESTHETICS SEGMENT INTO A REGIONAL AESTHETIC GROUP

Source text for Eikon:  urn:newsml:reuters.com:*:nSNZcf5lfH
Further company coverage:  ACCR.SI 

 ((Reuters.Briefs@thomsonreuters.com;))